Divis Laboratories Ltd share price logo

Divis Laboratories Share Price

NSE: DIVISLAB

BSE: 532488

Large Cap

Healthcare Sector

₹6100.00

+127.50

(+2.13%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Divis Laboratories Stock Performance

as on March 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹6,030.50
    ₹6,180.00
    downward going graph

    1.14%

    Downside

    1.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹4,955.00
    ₹7,071.50
    downward going graph

    18.77%

    Downside

    15.93%

    Upside

    downward going graph

Divis Laboratories share price movements today

Previous Close
₹5,972.50
Open
₹6,050.00
Volume
2.83L
Upper Circuit
₹6,569.50
Lower Circuit
₹5,375.50
Day's Low - High
₹6,030.50 - ₹6,180.00
52 Week Low - High
₹4,955.00 - ₹7,071.50

Divis Laboratories Historical Returns

1 Month Return
-5.06 %
3 Month Return
-8.28 %
1 Year Return
+ 2.58 %
3 Year Return
+ 113.29 %
5 Year Return
+ 75.35 %

Divis Laboratories Fundamentals

as on March 20, 2026 at 4:01 pm IST

Market Cap

₹1,58,551.11 Cr

Return on Equity (ROE)

15.57

PE Ratio (TTM)

63.97

Return on capital employed (ROCE)

20.63

Industry PE ratio

41.45

Beta (LTM)

0.74

P/B Ratio

10.27

Dividend Yield

0.52

PEG Ratio

4.12

Quarterly Earnings Growth YOY

-1.02

EPS (TTM)

82.68

Sector

Pharmaceuticals

Book Value

564.87

Technical Analysis

Bearish

View Technical Analysis

Divis Laboratories Stock Valuation

as on March 20, 2026 at 4:01 pm IST

Divis Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (41.45x)

March 19, 2026

Today (63.97x)

March 19, 2026

Highest (90.48x)

December 4, 2024

LowHigh

Today’s Price to Earnings Ratio: 63.97x

Divis Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Divis Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY1,58,551.1115.07%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,42,512.6148.77%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY59,738.56-1.68%0.781,42915,261
Gland Pharma Ltd image
Gland Pharma Ltd
BUY26,308.31-7.16%0.536985,616
Cipla Ltd image
Cipla Ltd
BUY1,00,100.4212.07%0.515,29127,547
See all

Market expectation of Divis Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

17.86%

Hold

32.14%

Sell

Divis Laboratories Stock’s Investor Sentiment and Interest

Investment in Divis Laboratories Ltd Shares on INDmoney has dropped by -45.85% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-45.85% versus previous 30 day period

Search interest for Divis Laboratories Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-46% versus previous 30 day period

Divis Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
1,951
1,778
1,909
1,855
2,303
2,118
2,338
2,319
2,585
2,410
2,715
2,604
Other Income
66
81
86
95
79
79
106
82
86
119
145
88
Total Income
2,017
1,859
1,995
1,950
2,382
2,197
2,444
2,401
2,671
2,529
2,860
2,692
Expenses
1,464
1,274
1,430
1,366
1,572
1,496
1,622
1,576
1,699
1,681
1,827
1,788
Operating Profit
487
504
479
489
731
622
716
743
886
729
888
816
Operating Profit Margin %
24.96%
28.35%
25.09%
26.36%
31.74%
29.37%
30.62%
32.04%
34.27%
30.25%
32.71%
31.34%
Profit Before Interest, Tax and Depreciation
553
585
565
584
810
701
822
825
972
848
1,033
904
Interest
-
-
1
-
2
-
1
-
1
3
8
6
Depreciation
87
93
95
95
95
97
99
99
107
112
113
118
Profit Before Tax
466
492
469
489
713
604
722
726
864
733
912
780
Tax Paid
145
136
121
131
175
174
212
137
202
188
223
197
Profit After Tax
321
356
348
358
538
430
510
589
662
545
689
583
Total Net profit including share of profit / Loss from associate company
321
356
348
358
538
430
510
589
662
545
689
583
EPS
12.09
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
Actual EPS
12.09
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
Adjusted EPS
12.09
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
Diluted EPS
12.09
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98

Divis Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
4,106.26
3,912.78
4,946.26
5,394.42
6,969.4
8,959.83
7,767
7,845
9,360
Other Income
74.89
113.44
155.63
189.63
62.56
113.87
345
339
352
Total Income
4,181.15
4,026.22
5,101.89
5,584.05
7,031.96
9,073.7
8,112
8,184
9,712
Expenses
2,660.23
2,651.07
3,074.42
3,572.25
4,109.46
5,077.89
5,399
5,640
6,392
Operating Profit
1,446.03
1,261.71
1,871.84
1,822.17
2,859.94
3,881.94
2,368
2,205
2,968
Operating Profit Margin %
35.22%
32.25%
37.84%
33.78%
41.04%
43.33%
30.49%
28.11%
31.71%
Profit Before Interest, Tax and Depreciation
1,520.92
1,375.15
2,027.47
2,011.8
2,922.5
3,995.81
2,713
2,544
3,320
Interest
2.25
1.33
3.5
6.1
0.87
0.8
1
3
2
Depreciation
123.33
142.49
168.9
186.24
255.59
311.51
343
378
402
Profit Before Tax
1,395.34
1,231.33
1,855.07
1,819.46
2,666.04
3,683.5
2,369
2,163
2,916
Tax Paid
334.92
354.32
502.33
442.92
681.75
723.05
545
563
725
Profit After Tax
1,060.42
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
Total Net profit including share of profit / Loss from associate company
1,060.42
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
EPS
39.95
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
Actual EPS
39.95
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
Adjusted EPS
39.95
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
Diluted EPS
39.95
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53

Divis Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,037.86
1,150.37
775.86
954.3
1,215.94
1,946.93
1,911.8
2,459.73
1,261
1,653
Cash Flow from Investing Activities
-406.41
-1,139.6
-478.3
-685.4
-83.47
75.13
-2,194.92
-2,707.62
-269
-804
Cash Flow from Financing Activities
-631.12
2.38
-314.16
-245.94
-1,091.42
-34.89
-532.44
-797.17
-799
-799
Net Cash Flow
0.33
13.15
-16.6
22.96
41.05
1,987.17
-815.56
-1,045.06
193
50

Divis Laboratories Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
51.93%
51.93%
51.92%
51.92%
51.9%
51.89%
51.89%
51.89%
51.89%
51.89%
51.88%
DII
21.23%
20.97%
21.88%
22.21%
21.77%
21.06%
20.54%
20.71%
19.05%
19.76%
19.28%
FII
0%
0%
14.86%
14.68%
16.16%
17.25%
17.99%
18.01%
19.74%
19.39%
20.08%
Public
12.14%
11.72%
11.33%
11.19%
10.18%
9.8%
9.59%
9.39%
9.32%
8.96%
8.76%
Total Outstanding Shares
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
Total Shareholders
4,02,155
3,73,860
3,54,482
3,47,629
2,98,310
2,78,899
2,80,601
2,67,755
2,59,825
2,49,634
2,33,844

Mutual Funds that own Divis Laboratories Stock

Check out the Mutual Funds with significant holdings in Divis Laboratories.

Divis Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Divis Laboratories.

  • Divis Laboratories Ltd Earnings Results

    Divis Laboratories Ltd’s net profit fell -1.02% since last year same period to ₹583.00Cr in the Q3 2025-2026. On a quarterly growth basis, Divis Laboratories Ltd has generated -15.38% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Divis Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Divis Laboratories Ltd has declared dividend of ₹30.00 per share on 17 May 2025 - translating a dividend yield of 1.00%.

    Read More about Dividends

Indices Featuring Divis Laboratories Stock

Check stock indices that include Divis Laboratories.

S&P BSE 100 ESG

₹386.72

0.49 (▲1.87%)

S&P BSE SEN. N50

₹78,010.25

0.59 (▲458.70%)

NIFTY PHARMA

₹22,540.70

1.99 (▲439.05%)

Nifty100 Eq Weig

₹31,179.15

0.62 (▲190.70%)

S&P BSE Momentum

₹2,007.86

0.38 (▲7.58%)

BSE 200

₹10,549.88

0.53 (▲55.21%)

Nifty Healthcare

₹14,383.45

1.89 (▲266.60%)

BSE Healthcare

₹42,306.40

1.45 (▲605.09%)

BSE 100

₹24,272.09

0.49 (▲118.42%)

NIFTY 100

₹23,766.10

0.48 (▲114.15%)

Nifty Next 50

₹63,862.30

0.45 (▲288.50%)

BSE MFG

₹1,032.11

0.90 (▲9.24%)

Nifty 200

₹12,985.40

0.52 (▲66.75%)

Nifty100 Quality

₹5,212.30

0.90 (▲46.25%)

S&P BSE Dividend Stability

₹992.89

0.90 (▲8.83%)

Nifty LargeMidcap 250

₹15,156.60

0.54 (▲80.70%)

S&P BSE 100 LargeCap TMC

₹8,587.41

0.47 (▲40.09%)

S&P BSE 250 LargeMidCap

₹10,004.10

0.51 (▲50.77%)

BSE 500

₹33,423.61

0.51 (▲168.45%)

Nifty 500

₹21,327.90

0.48 (▲102.10%)

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 19.39% to 20.08% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 30.3% return, outperforming this stock by 27.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 176.7% return, outperforming this stock by 63.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 689.0 Cr → 583.0 Cr (in ₹), with an average decrease of 15.4% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 51.89% to 51.88% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.96% to 8.76% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.86K Cr → 2.69K Cr (in ₹), with an average decrease of 5.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, DIVISLAB stock has moved down by -2.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 13.99% to 13.73% in Dec 2025 quarter

Divis Laboratories Stock Futures & Options Contracts

View the latest movement in Divis Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.

Divis Laboratories Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 30 Mar ₹6100 Call
March 30, 2026
₹6100
₹112.35
50.85
82.68%
DIVISLAB 30 Mar ₹6200 Call
March 30, 2026
₹6200
₹63.05
27.4
76.86%
DIVISLAB 30 Mar ₹6300 Call
March 30, 2026
₹6300
₹36
13.9
62.9%
DIVISLAB 30 Mar ₹6050 Call
March 30, 2026
₹6050
₹136.95
58.2
73.9%

Divis Laboratories Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 30 Mar Fut
March 30, 2026
-
₹6115
138.07
2.31%
DIVISLAB 28 Apr Fut
April 28, 2026
-
₹6155
140.74
2.34%
DIVISLAB 26 May Fut
May 26, 2026
-
₹6210
146.14
2.41%

About Divis Laboratories Ltd

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Revenue: ₹2,604.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹583.00Cr as on December 2025 (Q3 FY26)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORamesh B V Nimmagadda
E-voting on sharesClick here to vote

FAQs

What is Divis Laboratories share price today?

Divis Laboratories share price today stands at ₹6100 as on at the close of the market. Divis Laboratories share today touched a day high of ₹6180 and a low of ₹6030.5.

What is the 52 week high and 52 week low range for Divis Laboratories share?

Divis Laboratories touched a 52 week high of ₹7071.5 and a 52 week low of ₹4955. Divis Laboratories share price today i.e. is closed at ₹6100, which is -13.74% down from its 52 week high and 23.11% up from its 52 week low.

What is Divis Laboratories's market capitalisation today?

Divis Laboratories market capitalisation is ₹1,58,551.11 Cr as on .

How to buy Divis Laboratories shares?

To buy Divis Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for DIVISLAB or Divis Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Divis Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Divis Laboratories trading volume today?

Divis Laboratories trading volume is 2.83L as on . This means that 2.83L shares of Divis Laboratories were bought and sold on the stock market during today's trading session.